nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CCR5—epilepsy syndrome	0.478	1	CbGaD
Maraviroc—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0223	0.0879	CbGbCtD
Maraviroc—CYP3A4—Felbamate—epilepsy syndrome	0.0207	0.0817	CbGbCtD
Maraviroc—CYP3A4—Trimethadione—epilepsy syndrome	0.0207	0.0817	CbGbCtD
Maraviroc—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0195	0.0768	CbGbCtD
Maraviroc—CYP3A4—Clonazepam—epilepsy syndrome	0.0176	0.0695	CbGbCtD
Maraviroc—CYP3A4—Clobazam—epilepsy syndrome	0.0169	0.0666	CbGbCtD
Maraviroc—CYP3A4—Rufinamide—epilepsy syndrome	0.0144	0.0566	CbGbCtD
Maraviroc—CYP3A4—Carbamazepine—epilepsy syndrome	0.014	0.0552	CbGbCtD
Maraviroc—CYP3A4—Primidone—epilepsy syndrome	0.0131	0.0515	CbGbCtD
Maraviroc—CYP3A4—Phenytoin—epilepsy syndrome	0.0126	0.0495	CbGbCtD
Maraviroc—CYP3A4—Propofol—epilepsy syndrome	0.0117	0.0462	CbGbCtD
Maraviroc—CYP3A4—Acetazolamide—epilepsy syndrome	0.0112	0.0441	CbGbCtD
Maraviroc—CYP3A4—Phenobarbital—epilepsy syndrome	0.0112	0.0441	CbGbCtD
Maraviroc—CYP3A4—Midazolam—epilepsy syndrome	0.011	0.0435	CbGbCtD
Maraviroc—CYP3A4—Diazepam—epilepsy syndrome	0.0106	0.0418	CbGbCtD
Maraviroc—CYP3A4—Zonisamide—epilepsy syndrome	0.0104	0.0408	CbGbCtD
Maraviroc—CYP3A4—Valproic Acid—epilepsy syndrome	0.00836	0.033	CbGbCtD
Maraviroc—CYP3A4—Topiramate—epilepsy syndrome	0.00755	0.0297	CbGbCtD
Maraviroc—CCR5—spinal cord—epilepsy syndrome	0.0014	0.23	CbGeAlD
Maraviroc—CCR5—head—epilepsy syndrome	0.00124	0.204	CbGeAlD
Maraviroc—CCR5—nervous system—epilepsy syndrome	0.00118	0.194	CbGeAlD
Maraviroc—CCR5—central nervous system—epilepsy syndrome	0.00113	0.186	CbGeAlD
Maraviroc—CCR5—brain—epilepsy syndrome	0.000899	0.148	CbGeAlD
Maraviroc—CYP3A4—nervous system—epilepsy syndrome	0.000119	0.0195	CbGeAlD
Maraviroc—CYP3A4—central nervous system—epilepsy syndrome	0.000114	0.0188	CbGeAlD
Maraviroc—CCR5—GPCR downstream signaling—HRH3—epilepsy syndrome	7.93e-05	0.000794	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CX3CR1—epilepsy syndrome	7.88e-05	0.000788	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—OPRM1—epilepsy syndrome	7.81e-05	0.000781	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CX3CL1—epilepsy syndrome	7.72e-05	0.000773	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—BDKRB1—epilepsy syndrome	7.72e-05	0.000773	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CHRM2—epilepsy syndrome	7.72e-05	0.000773	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	7.72e-05	0.000772	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—GABBR1—epilepsy syndrome	7.51e-05	0.000752	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCR3—epilepsy syndrome	7.37e-05	0.000738	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	7.34e-05	0.000734	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HRH3—epilepsy syndrome	7.2e-05	0.000721	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—NPY—epilepsy syndrome	7.19e-05	0.000719	CbGpPWpGaD
Maraviroc—CCR5—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	7.18e-05	0.000718	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—OPRM1—epilepsy syndrome	7.09e-05	0.000709	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM2—epilepsy syndrome	7.08e-05	0.000708	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—HTR2A—epilepsy syndrome	7e-05	0.0007	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CRH—epilepsy syndrome	6.93e-05	0.000694	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—OXT—epilepsy syndrome	6.93e-05	0.000694	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL2—epilepsy syndrome	6.93e-05	0.000694	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR3—epilepsy syndrome	6.7e-05	0.00067	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—AGT—epilepsy syndrome	6.64e-05	0.000664	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—NPY—epilepsy syndrome	6.53e-05	0.000653	CbGpPWpGaD
Maraviroc—CCR5—Disease—EIF2AK2—epilepsy syndrome	6.52e-05	0.000652	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SSTR3—epilepsy syndrome	6.4e-05	0.000641	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CRH—epilepsy syndrome	6.3e-05	0.00063	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCL3—epilepsy syndrome	6.3e-05	0.00063	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—OXT—epilepsy syndrome	6.3e-05	0.00063	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL2—epilepsy syndrome	6.3e-05	0.00063	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—SST—epilepsy syndrome	6.27e-05	0.000627	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CCR2—epilepsy syndrome	6.27e-05	0.000627	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ST3GAL3—epilepsy syndrome	6.27e-05	0.000627	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SSTR1—epilepsy syndrome	6.14e-05	0.000614	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR9—epilepsy syndrome	6.14e-05	0.000614	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR8—epilepsy syndrome	6.14e-05	0.000614	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ARHGEF9—epilepsy syndrome	6.14e-05	0.000614	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPY2R—epilepsy syndrome	6.14e-05	0.000614	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—ADRA2A—epilepsy syndrome	6.14e-05	0.000614	CbGpPWpGaD
Maraviroc—CCR5—Disease—PPIA—epilepsy syndrome	6.03e-05	0.000603	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM3—epilepsy syndrome	6.02e-05	0.000602	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM4—epilepsy syndrome	6.02e-05	0.000602	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—KCNAB2—epilepsy syndrome	6.01e-05	0.000601	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—DUSP4—epilepsy syndrome	5.91e-05	0.000591	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SSTR2—epilepsy syndrome	5.91e-05	0.000591	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CXCL12—epilepsy syndrome	5.9e-05	0.00059	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—BDKRB2—epilepsy syndrome	5.9e-05	0.00059	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CNR1—epilepsy syndrome	5.79e-05	0.000579	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PLCB1—epilepsy syndrome	5.77e-05	0.000577	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM8—epilepsy syndrome	5.71e-05	0.000571	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PGF—epilepsy syndrome	5.71e-05	0.000571	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—SST—epilepsy syndrome	5.69e-05	0.00057	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CCR2—epilepsy syndrome	5.69e-05	0.00057	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR7—epilepsy syndrome	5.65e-05	0.000565	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—POMC—epilepsy syndrome	5.59e-05	0.000559	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—ADRA2A—epilepsy syndrome	5.57e-05	0.000557	CbGpPWpGaD
Maraviroc—CCR5—GPCR ligand binding—CCL2—epilepsy syndrome	5.47e-05	0.000547	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—OPRD1—epilepsy syndrome	5.44e-05	0.000545	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GNAO1—epilepsy syndrome	5.44e-05	0.000545	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT3—epilepsy syndrome	5.38e-05	0.000538	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—BDKRB2—epilepsy syndrome	5.35e-05	0.000536	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CXCL12—epilepsy syndrome	5.35e-05	0.000536	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CNR1—epilepsy syndrome	5.26e-05	0.000526	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PLCB1—epilepsy syndrome	5.24e-05	0.000524	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CHRM1—epilepsy syndrome	5.22e-05	0.000522	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCR7—epilepsy syndrome	5.22e-05	0.000522	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM1—epilepsy syndrome	5.22e-05	0.000522	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PDYN—epilepsy syndrome	5.22e-05	0.000522	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HTR7—epilepsy syndrome	5.13e-05	0.000513	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—HBEGF—epilepsy syndrome	4.98e-05	0.000498	CbGpPWpGaD
Maraviroc—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	4.94e-05	0.000494	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—CDC42—epilepsy syndrome	4.91e-05	0.000491	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GAL—epilepsy syndrome	4.91e-05	0.000491	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GFAP—epilepsy syndrome	4.91e-05	0.000491	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT3—epilepsy syndrome	4.89e-05	0.000489	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CHRM3—epilepsy syndrome	4.85e-05	0.000485	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GRM5—epilepsy syndrome	4.85e-05	0.000485	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASP2—epilepsy syndrome	4.85e-05	0.000485	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AVP—epilepsy syndrome	4.75e-05	0.000475	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—epilepsy syndrome	4.71e-05	0.000471	CbGpPWpGaD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—epilepsy syndrome	4.7e-05	0.00047	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	4.67e-05	0.000467	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CX3CR1—epilepsy syndrome	4.65e-05	0.000465	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	4.64e-05	0.000464	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	4.61e-05	0.000461	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	4.58e-05	0.000458	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CX3CL1—epilepsy syndrome	4.56e-05	0.000456	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CHRM2—epilepsy syndrome	4.56e-05	0.000456	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BDKRB1—epilepsy syndrome	4.56e-05	0.000456	CbGpPWpGaD
Maraviroc—CCR5—Disease—SLC2A1—epilepsy syndrome	4.47e-05	0.000447	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—CDC42—epilepsy syndrome	4.46e-05	0.000446	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GABBR1—epilepsy syndrome	4.44e-05	0.000444	CbGpPWpGaD
Maraviroc—CCR5—Disease—JUNB—epilepsy syndrome	4.43e-05	0.000443	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS1—epilepsy syndrome	4.4e-05	0.00044	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AVP—epilepsy syndrome	4.32e-05	0.000432	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HRH3—epilepsy syndrome	4.26e-05	0.000426	CbGpPWpGaD
Maraviroc—CCR5—Disease—HBEGF—epilepsy syndrome	4.2e-05	0.00042	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—OPRM1—epilepsy syndrome	4.19e-05	0.000419	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	4.19e-05	0.000419	CbGpPWpGaD
Maraviroc—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	4.13e-05	0.000413	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT3—epilepsy syndrome	4.12e-05	0.000412	CbGpPWpGaD
Maraviroc—CCR5—Disease—ADAM10—epilepsy syndrome	4.03e-05	0.000403	CbGpPWpGaD
Maraviroc—Anaemia—Pregabalin—epilepsy syndrome	3.97e-05	0.000245	CcSEcCtD
Maraviroc—Dermatitis—Levetiracetam—epilepsy syndrome	3.97e-05	0.000245	CcSEcCtD
Maraviroc—Asthenia—Zonisamide—epilepsy syndrome	3.96e-05	0.000245	CcSEcCtD
Maraviroc—Mental disorder—Gabapentin—epilepsy syndrome	3.96e-05	0.000245	CcSEcCtD
Maraviroc—Agranulocytosis—Topiramate—epilepsy syndrome	3.96e-05	0.000245	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCR3—epilepsy syndrome	3.96e-05	0.000396	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.95e-05	0.000396	CbGpPWpGaD
Maraviroc—Headache—Levetiracetam—epilepsy syndrome	3.94e-05	0.000244	CcSEcCtD
Maraviroc—Malnutrition—Gabapentin—epilepsy syndrome	3.94e-05	0.000244	CcSEcCtD
Maraviroc—Erythema—Gabapentin—epilepsy syndrome	3.94e-05	0.000244	CcSEcCtD
Maraviroc—Hypersensitivity—Clonazepam—epilepsy syndrome	3.92e-05	0.000243	CcSEcCtD
Maraviroc—Dizziness—Vigabatrin—epilepsy syndrome	3.92e-05	0.000242	CcSEcCtD
Maraviroc—Pruritus—Zonisamide—epilepsy syndrome	3.91e-05	0.000242	CcSEcCtD
Maraviroc—Hypersensitivity—Phenytoin—epilepsy syndrome	3.9e-05	0.000241	CcSEcCtD
Maraviroc—Flatulence—Gabapentin—epilepsy syndrome	3.88e-05	0.00024	CcSEcCtD
Maraviroc—Oedema—Valproic Acid—epilepsy syndrome	3.88e-05	0.00024	CcSEcCtD
Maraviroc—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.88e-05	0.00024	CcSEcCtD
Maraviroc—Nausea—Propofol—epilepsy syndrome	3.87e-05	0.000239	CcSEcCtD
Maraviroc—Vomiting—Fosphenytoin—epilepsy syndrome	3.86e-05	0.000239	CcSEcCtD
Maraviroc—Diarrhoea—Felbamate—epilepsy syndrome	3.86e-05	0.000239	CcSEcCtD
Maraviroc—Abdominal pain—Lamotrigine—epilepsy syndrome	3.86e-05	0.000239	CcSEcCtD
Maraviroc—Body temperature increased—Lamotrigine—epilepsy syndrome	3.86e-05	0.000239	CcSEcCtD
Maraviroc—Dizziness—Diazepam—epilepsy syndrome	3.86e-05	0.000238	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ATP2A2—epilepsy syndrome	3.86e-05	0.000386	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NPY—epilepsy syndrome	3.86e-05	0.000386	CbGpPWpGaD
Maraviroc—Infection—Valproic Acid—epilepsy syndrome	3.85e-05	0.000238	CcSEcCtD
Maraviroc—Syncope—Pregabalin—epilepsy syndrome	3.85e-05	0.000238	CcSEcCtD
Maraviroc—Leukopenia—Pregabalin—epilepsy syndrome	3.84e-05	0.000238	CcSEcCtD
Maraviroc—Rash—Fosphenytoin—epilepsy syndrome	3.83e-05	0.000237	CcSEcCtD
Maraviroc—Dermatitis—Fosphenytoin—epilepsy syndrome	3.83e-05	0.000237	CcSEcCtD
Maraviroc—Asthenia—Clonazepam—epilepsy syndrome	3.82e-05	0.000236	CcSEcCtD
Maraviroc—Rhinitis—Topiramate—epilepsy syndrome	3.82e-05	0.000236	CcSEcCtD
Maraviroc—Headache—Fosphenytoin—epilepsy syndrome	3.81e-05	0.000235	CcSEcCtD
Maraviroc—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.8e-05	0.000235	CcSEcCtD
Maraviroc—CYP3A4—Tryptophan metabolism—CAT—epilepsy syndrome	3.8e-05	0.00038	CbGpPWpGaD
Maraviroc—Asthenia—Phenytoin—epilepsy syndrome	3.79e-05	0.000235	CcSEcCtD
Maraviroc—Nausea—Midazolam—epilepsy syndrome	3.79e-05	0.000234	CcSEcCtD
Maraviroc—Hallucination—Topiramate—epilepsy syndrome	3.79e-05	0.000234	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	3.78e-05	0.000378	CbGpPWpGaD
Maraviroc—Diarrhoea—Zonisamide—epilepsy syndrome	3.78e-05	0.000234	CcSEcCtD
Maraviroc—Pharyngitis—Topiramate—epilepsy syndrome	3.78e-05	0.000234	CcSEcCtD
Maraviroc—Loss of consciousness—Pregabalin—epilepsy syndrome	3.77e-05	0.000233	CcSEcCtD
Maraviroc—Asthenia—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.000233	CcSEcCtD
Maraviroc—Pruritus—Clonazepam—epilepsy syndrome	3.77e-05	0.000233	CcSEcCtD
Maraviroc—Vomiting—Vigabatrin—epilepsy syndrome	3.77e-05	0.000233	CcSEcCtD
Maraviroc—Skin disorder—Valproic Acid—epilepsy syndrome	3.77e-05	0.000233	CcSEcCtD
Maraviroc—CCR5—Disease—CDC42—epilepsy syndrome	3.76e-05	0.000376	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	3.76e-05	0.000376	CbGpPWpGaD
Maraviroc—Urinary tract disorder—Topiramate—epilepsy syndrome	3.76e-05	0.000232	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—AGT—epilepsy syndrome	3.75e-05	0.000375	CbGpPWpGaD
Maraviroc—Cough—Pregabalin—epilepsy syndrome	3.75e-05	0.000232	CcSEcCtD
Maraviroc—Pruritus—Phenytoin—epilepsy syndrome	3.74e-05	0.000231	CcSEcCtD
Maraviroc—Connective tissue disorder—Topiramate—epilepsy syndrome	3.74e-05	0.000231	CcSEcCtD
Maraviroc—Nausea—Levetiracetam—epilepsy syndrome	3.74e-05	0.000231	CcSEcCtD
Maraviroc—Rash—Vigabatrin—epilepsy syndrome	3.73e-05	0.000231	CcSEcCtD
Maraviroc—Dizziness—Felbamate—epilepsy syndrome	3.73e-05	0.000231	CcSEcCtD
Maraviroc—Dermatitis—Vigabatrin—epilepsy syndrome	3.73e-05	0.000231	CcSEcCtD
Maraviroc—Urethral disorder—Topiramate—epilepsy syndrome	3.73e-05	0.000231	CcSEcCtD
Maraviroc—Pruritus—Oxcarbazepine—epilepsy syndrome	3.72e-05	0.00023	CcSEcCtD
Maraviroc—Convulsion—Pregabalin—epilepsy syndrome	3.72e-05	0.00023	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HSPB1—epilepsy syndrome	3.72e-05	0.000372	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CRH—epilepsy syndrome	3.72e-05	0.000372	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—OXT—epilepsy syndrome	3.72e-05	0.000372	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL3—epilepsy syndrome	3.72e-05	0.000372	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL2—epilepsy syndrome	3.72e-05	0.000372	CbGpPWpGaD
Maraviroc—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.72e-05	0.00023	CcSEcCtD
Maraviroc—Headache—Vigabatrin—epilepsy syndrome	3.71e-05	0.000229	CcSEcCtD
Maraviroc—Vomiting—Diazepam—epilepsy syndrome	3.71e-05	0.000229	CcSEcCtD
Maraviroc—Anorexia—Valproic Acid—epilepsy syndrome	3.7e-05	0.000229	CcSEcCtD
Maraviroc—Tremor—Gabapentin—epilepsy syndrome	3.69e-05	0.000228	CcSEcCtD
Maraviroc—Rash—Diazepam—epilepsy syndrome	3.68e-05	0.000227	CcSEcCtD
Maraviroc—Dermatitis—Diazepam—epilepsy syndrome	3.67e-05	0.000227	CcSEcCtD
Maraviroc—Myalgia—Pregabalin—epilepsy syndrome	3.66e-05	0.000226	CcSEcCtD
Maraviroc—Dizziness—Zonisamide—epilepsy syndrome	3.65e-05	0.000226	CcSEcCtD
Maraviroc—Headache—Diazepam—epilepsy syndrome	3.65e-05	0.000226	CcSEcCtD
Maraviroc—Anxiety—Pregabalin—epilepsy syndrome	3.64e-05	0.000225	CcSEcCtD
Maraviroc—Diarrhoea—Clonazepam—epilepsy syndrome	3.64e-05	0.000225	CcSEcCtD
Maraviroc—Anaemia—Gabapentin—epilepsy syndrome	3.64e-05	0.000225	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.63e-05	0.000225	CcSEcCtD
Maraviroc—Asthenia—Carbamazepine—epilepsy syndrome	3.62e-05	0.000224	CcSEcCtD
Maraviroc—Diarrhoea—Phenytoin—epilepsy syndrome	3.62e-05	0.000224	CcSEcCtD
Maraviroc—Discomfort—Pregabalin—epilepsy syndrome	3.61e-05	0.000223	CcSEcCtD
Maraviroc—Nausea—Fosphenytoin—epilepsy syndrome	3.61e-05	0.000223	CcSEcCtD
Maraviroc—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.6e-05	0.000223	CcSEcCtD
Maraviroc—Erythema multiforme—Topiramate—epilepsy syndrome	3.6e-05	0.000223	CcSEcCtD
Maraviroc—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.59e-05	0.000222	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—epilepsy syndrome	3.59e-05	0.000359	CbGpPWpGaD
Maraviroc—Vomiting—Felbamate—epilepsy syndrome	3.59e-05	0.000222	CcSEcCtD
Maraviroc—Pruritus—Carbamazepine—epilepsy syndrome	3.57e-05	0.000221	CcSEcCtD
Maraviroc—Rash—Felbamate—epilepsy syndrome	3.56e-05	0.00022	CcSEcCtD
Maraviroc—Eye disorder—Topiramate—epilepsy syndrome	3.56e-05	0.00022	CcSEcCtD
Maraviroc—Dermatitis—Felbamate—epilepsy syndrome	3.56e-05	0.00022	CcSEcCtD
Maraviroc—Headache—Felbamate—epilepsy syndrome	3.54e-05	0.000219	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.53e-05	0.000218	CcSEcCtD
Maraviroc—Cardiac disorder—Topiramate—epilepsy syndrome	3.53e-05	0.000218	CcSEcCtD
Maraviroc—Syncope—Gabapentin—epilepsy syndrome	3.53e-05	0.000218	CcSEcCtD
Maraviroc—Leukopenia—Gabapentin—epilepsy syndrome	3.53e-05	0.000218	CcSEcCtD
Maraviroc—Dizziness—Clonazepam—epilepsy syndrome	3.52e-05	0.000218	CcSEcCtD
Maraviroc—Nausea—Vigabatrin—epilepsy syndrome	3.52e-05	0.000218	CcSEcCtD
Maraviroc—Vomiting—Zonisamide—epilepsy syndrome	3.51e-05	0.000217	CcSEcCtD
Maraviroc—Insomnia—Valproic Acid—epilepsy syndrome	3.51e-05	0.000217	CcSEcCtD
Maraviroc—Oedema—Pregabalin—epilepsy syndrome	3.51e-05	0.000217	CcSEcCtD
Maraviroc—Asthenia—Lamotrigine—epilepsy syndrome	3.5e-05	0.000217	CcSEcCtD
Maraviroc—Dizziness—Phenytoin—epilepsy syndrome	3.5e-05	0.000216	CcSEcCtD
Maraviroc—Rash—Zonisamide—epilepsy syndrome	3.48e-05	0.000215	CcSEcCtD
Maraviroc—Infection—Pregabalin—epilepsy syndrome	3.48e-05	0.000215	CcSEcCtD
Maraviroc—Paraesthesia—Valproic Acid—epilepsy syndrome	3.48e-05	0.000215	CcSEcCtD
Maraviroc—Dermatitis—Zonisamide—epilepsy syndrome	3.48e-05	0.000215	CcSEcCtD
Maraviroc—Dizziness—Oxcarbazepine—epilepsy syndrome	3.48e-05	0.000215	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.47e-05	0.000347	CbGpPWpGaD
Maraviroc—Nausea—Diazepam—epilepsy syndrome	3.46e-05	0.000214	CcSEcCtD
Maraviroc—Loss of consciousness—Gabapentin—epilepsy syndrome	3.46e-05	0.000214	CcSEcCtD
Maraviroc—Headache—Zonisamide—epilepsy syndrome	3.46e-05	0.000214	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TSC1—epilepsy syndrome	3.46e-05	0.000346	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PTK2B—epilepsy syndrome	3.46e-05	0.000346	CbGpPWpGaD
Maraviroc—Diarrhoea—Carbamazepine—epilepsy syndrome	3.45e-05	0.000214	CcSEcCtD
Maraviroc—Angiopathy—Topiramate—epilepsy syndrome	3.45e-05	0.000214	CcSEcCtD
Maraviroc—Pruritus—Lamotrigine—epilepsy syndrome	3.45e-05	0.000213	CcSEcCtD
Maraviroc—Shock—Pregabalin—epilepsy syndrome	3.45e-05	0.000213	CcSEcCtD
Maraviroc—CCR5—Disease—HES1—epilepsy syndrome	3.44e-05	0.000344	CbGpPWpGaD
Maraviroc—Nervous system disorder—Pregabalin—epilepsy syndrome	3.44e-05	0.000213	CcSEcCtD
Maraviroc—Cough—Gabapentin—epilepsy syndrome	3.44e-05	0.000213	CcSEcCtD
Maraviroc—Mediastinal disorder—Topiramate—epilepsy syndrome	3.43e-05	0.000212	CcSEcCtD
Maraviroc—Convulsion—Gabapentin—epilepsy syndrome	3.41e-05	0.000211	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—AGT—epilepsy syndrome	3.41e-05	0.000341	CbGpPWpGaD
Maraviroc—Skin disorder—Pregabalin—epilepsy syndrome	3.4e-05	0.000211	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	3.39e-05	0.000339	CbGpPWpGaD
Maraviroc—Vomiting—Clonazepam—epilepsy syndrome	3.39e-05	0.000209	CcSEcCtD
Maraviroc—Decreased appetite—Valproic Acid—epilepsy syndrome	3.37e-05	0.000208	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCR2—epilepsy syndrome	3.36e-05	0.000336	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SST—epilepsy syndrome	3.36e-05	0.000336	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NTRK2—epilepsy syndrome	3.36e-05	0.000336	CbGpPWpGaD
Maraviroc—Alopecia—Topiramate—epilepsy syndrome	3.36e-05	0.000208	CcSEcCtD
Maraviroc—Vomiting—Phenytoin—epilepsy syndrome	3.36e-05	0.000208	CcSEcCtD
Maraviroc—Rash—Clonazepam—epilepsy syndrome	3.36e-05	0.000208	CcSEcCtD
Maraviroc—Dermatitis—Clonazepam—epilepsy syndrome	3.35e-05	0.000207	CcSEcCtD
Maraviroc—Myalgia—Gabapentin—epilepsy syndrome	3.35e-05	0.000207	CcSEcCtD
Maraviroc—Nausea—Felbamate—epilepsy syndrome	3.35e-05	0.000207	CcSEcCtD
Maraviroc—CCR5—Disease—FYN—epilepsy syndrome	3.35e-05	0.000335	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.35e-05	0.000207	CcSEcCtD
Maraviroc—Vomiting—Oxcarbazepine—epilepsy syndrome	3.34e-05	0.000207	CcSEcCtD
Maraviroc—Fatigue—Valproic Acid—epilepsy syndrome	3.34e-05	0.000207	CcSEcCtD
Maraviroc—Anxiety—Gabapentin—epilepsy syndrome	3.34e-05	0.000207	CcSEcCtD
Maraviroc—Anorexia—Pregabalin—epilepsy syndrome	3.34e-05	0.000207	CcSEcCtD
Maraviroc—Dizziness—Carbamazepine—epilepsy syndrome	3.34e-05	0.000206	CcSEcCtD
Maraviroc—Diarrhoea—Lamotrigine—epilepsy syndrome	3.34e-05	0.000206	CcSEcCtD
Maraviroc—CCR5—Disease—H2AFX—epilepsy syndrome	3.34e-05	0.000334	CbGpPWpGaD
Maraviroc—Headache—Clonazepam—epilepsy syndrome	3.34e-05	0.000206	CcSEcCtD
Maraviroc—Rash—Phenytoin—epilepsy syndrome	3.33e-05	0.000206	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—DUSP6—epilepsy syndrome	3.33e-05	0.000334	CbGpPWpGaD
Maraviroc—Mental disorder—Topiramate—epilepsy syndrome	3.33e-05	0.000206	CcSEcCtD
Maraviroc—Dermatitis—Phenytoin—epilepsy syndrome	3.33e-05	0.000206	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.33e-05	0.000206	CcSEcCtD
Maraviroc—Rash—Oxcarbazepine—epilepsy syndrome	3.32e-05	0.000205	CcSEcCtD
Maraviroc—Constipation—Valproic Acid—epilepsy syndrome	3.32e-05	0.000205	CcSEcCtD
Maraviroc—Pain—Valproic Acid—epilepsy syndrome	3.32e-05	0.000205	CcSEcCtD
Maraviroc—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.31e-05	0.000205	CcSEcCtD
Maraviroc—Headache—Phenytoin—epilepsy syndrome	3.31e-05	0.000205	CcSEcCtD
Maraviroc—Malnutrition—Topiramate—epilepsy syndrome	3.31e-05	0.000205	CcSEcCtD
Maraviroc—Erythema—Topiramate—epilepsy syndrome	3.31e-05	0.000205	CcSEcCtD
Maraviroc—Discomfort—Gabapentin—epilepsy syndrome	3.31e-05	0.000205	CcSEcCtD
Maraviroc—Headache—Oxcarbazepine—epilepsy syndrome	3.3e-05	0.000204	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADRA2A—epilepsy syndrome	3.29e-05	0.000329	CbGpPWpGaD
Maraviroc—Nausea—Zonisamide—epilepsy syndrome	3.28e-05	0.000203	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PLAT—epilepsy syndrome	3.28e-05	0.000328	CbGpPWpGaD
Maraviroc—Flatulence—Topiramate—epilepsy syndrome	3.26e-05	0.000202	CcSEcCtD
Maraviroc—Dizziness—Lamotrigine—epilepsy syndrome	3.23e-05	0.0002	CcSEcCtD
Maraviroc—CCR5—Disease—YWHAZ—epilepsy syndrome	3.22e-05	0.000322	CbGpPWpGaD
Maraviroc—Oedema—Gabapentin—epilepsy syndrome	3.21e-05	0.000199	CcSEcCtD
Maraviroc—Vomiting—Carbamazepine—epilepsy syndrome	3.21e-05	0.000199	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.19e-05	0.000198	CcSEcCtD
Maraviroc—Infection—Gabapentin—epilepsy syndrome	3.19e-05	0.000197	CcSEcCtD
Maraviroc—Rash—Carbamazepine—epilepsy syndrome	3.18e-05	0.000197	CcSEcCtD
Maraviroc—Dermatitis—Carbamazepine—epilepsy syndrome	3.18e-05	0.000197	CcSEcCtD
Maraviroc—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.17e-05	0.000196	CcSEcCtD
Maraviroc—Insomnia—Pregabalin—epilepsy syndrome	3.17e-05	0.000196	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—BDKRB2—epilepsy syndrome	3.16e-05	0.000316	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL12—epilepsy syndrome	3.16e-05	0.000316	CbGpPWpGaD
Maraviroc—Nausea—Clonazepam—epilepsy syndrome	3.16e-05	0.000196	CcSEcCtD
Maraviroc—Headache—Carbamazepine—epilepsy syndrome	3.16e-05	0.000196	CcSEcCtD
Maraviroc—Shock—Gabapentin—epilepsy syndrome	3.16e-05	0.000196	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—POMC—epilepsy syndrome	3.16e-05	0.000316	CbGpPWpGaD
Maraviroc—Nervous system disorder—Gabapentin—epilepsy syndrome	3.15e-05	0.000195	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—PRKCB—epilepsy syndrome	3.15e-05	0.000315	CbGpPWpGaD
Maraviroc—Paraesthesia—Pregabalin—epilepsy syndrome	3.15e-05	0.000195	CcSEcCtD
Maraviroc—Nausea—Phenytoin—epilepsy syndrome	3.14e-05	0.000194	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6ST—epilepsy syndrome	3.14e-05	0.000314	CbGpPWpGaD
Maraviroc—Nausea—Oxcarbazepine—epilepsy syndrome	3.12e-05	0.000193	CcSEcCtD
Maraviroc—Skin disorder—Gabapentin—epilepsy syndrome	3.12e-05	0.000193	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CNR1—epilepsy syndrome	3.1e-05	0.000311	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JUNB—epilepsy syndrome	3.1e-05	0.000311	CbGpPWpGaD
Maraviroc—Tremor—Topiramate—epilepsy syndrome	3.1e-05	0.000192	CcSEcCtD
Maraviroc—Vomiting—Lamotrigine—epilepsy syndrome	3.1e-05	0.000192	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PLCB1—epilepsy syndrome	3.09e-05	0.000309	CbGpPWpGaD
Maraviroc—Rash—Lamotrigine—epilepsy syndrome	3.08e-05	0.00019	CcSEcCtD
Maraviroc—Dermatitis—Lamotrigine—epilepsy syndrome	3.07e-05	0.00019	CcSEcCtD
Maraviroc—Abdominal pain—Valproic Acid—epilepsy syndrome	3.06e-05	0.00019	CcSEcCtD
Maraviroc—Body temperature increased—Valproic Acid—epilepsy syndrome	3.06e-05	0.00019	CcSEcCtD
Maraviroc—Anorexia—Gabapentin—epilepsy syndrome	3.06e-05	0.000189	CcSEcCtD
Maraviroc—Anaemia—Topiramate—epilepsy syndrome	3.06e-05	0.000189	CcSEcCtD
Maraviroc—Headache—Lamotrigine—epilepsy syndrome	3.06e-05	0.000189	CcSEcCtD
Maraviroc—Decreased appetite—Pregabalin—epilepsy syndrome	3.05e-05	0.000188	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR7—epilepsy syndrome	3.03e-05	0.000303	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.03e-05	0.000187	CcSEcCtD
Maraviroc—Fatigue—Pregabalin—epilepsy syndrome	3.02e-05	0.000187	CcSEcCtD
Maraviroc—Nausea—Carbamazepine—epilepsy syndrome	3e-05	0.000185	CcSEcCtD
Maraviroc—Pain—Pregabalin—epilepsy syndrome	3e-05	0.000185	CcSEcCtD
Maraviroc—Constipation—Pregabalin—epilepsy syndrome	3e-05	0.000185	CcSEcCtD
Maraviroc—Syncope—Topiramate—epilepsy syndrome	2.97e-05	0.000184	CcSEcCtD
Maraviroc—Leukopenia—Topiramate—epilepsy syndrome	2.97e-05	0.000183	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HBEGF—epilepsy syndrome	2.94e-05	0.000294	CbGpPWpGaD
Maraviroc—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.93e-05	0.000181	CcSEcCtD
Maraviroc—Loss of consciousness—Topiramate—epilepsy syndrome	2.91e-05	0.00018	CcSEcCtD
Maraviroc—Insomnia—Gabapentin—epilepsy syndrome	2.91e-05	0.00018	CcSEcCtD
Maraviroc—Nausea—Lamotrigine—epilepsy syndrome	2.9e-05	0.000179	CcSEcCtD
Maraviroc—Cough—Topiramate—epilepsy syndrome	2.89e-05	0.000179	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—AKT3—epilepsy syndrome	2.89e-05	0.000289	CbGpPWpGaD
Maraviroc—Paraesthesia—Gabapentin—epilepsy syndrome	2.89e-05	0.000178	CcSEcCtD
Maraviroc—CCR5—Disease—TSC2—epilepsy syndrome	2.88e-05	0.000288	CbGpPWpGaD
Maraviroc—Convulsion—Topiramate—epilepsy syndrome	2.87e-05	0.000178	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—POMC—epilepsy syndrome	2.87e-05	0.000287	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.87e-05	0.000177	CcSEcCtD
Maraviroc—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.86e-05	0.000177	CcSEcCtD
Maraviroc—Myalgia—Topiramate—epilepsy syndrome	2.82e-05	0.000174	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADAM10—epilepsy syndrome	2.82e-05	0.000282	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOE—epilepsy syndrome	2.82e-05	0.000282	CbGpPWpGaD
Maraviroc—Anxiety—Topiramate—epilepsy syndrome	2.81e-05	0.000174	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CCL2—epilepsy syndrome	2.81e-05	0.000281	CbGpPWpGaD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.8e-05	0.000173	CcSEcCtD
Maraviroc—Decreased appetite—Gabapentin—epilepsy syndrome	2.79e-05	0.000173	CcSEcCtD
Maraviroc—Discomfort—Topiramate—epilepsy syndrome	2.79e-05	0.000172	CcSEcCtD
Maraviroc—Asthenia—Valproic Acid—epilepsy syndrome	2.78e-05	0.000172	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.77e-05	0.000172	CcSEcCtD
Maraviroc—Fatigue—Gabapentin—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Maraviroc—Abdominal pain—Pregabalin—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Maraviroc—Body temperature increased—Pregabalin—epilepsy syndrome	2.77e-05	0.000171	CcSEcCtD
Maraviroc—Pain—Gabapentin—epilepsy syndrome	2.75e-05	0.00017	CcSEcCtD
Maraviroc—Constipation—Gabapentin—epilepsy syndrome	2.75e-05	0.00017	CcSEcCtD
Maraviroc—Pruritus—Valproic Acid—epilepsy syndrome	2.74e-05	0.00017	CcSEcCtD
Maraviroc—Oedema—Topiramate—epilepsy syndrome	2.7e-05	0.000167	CcSEcCtD
Maraviroc—Infection—Topiramate—epilepsy syndrome	2.69e-05	0.000166	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—S100B—epilepsy syndrome	2.67e-05	0.000267	CbGpPWpGaD
Maraviroc—Shock—Topiramate—epilepsy syndrome	2.66e-05	0.000165	CcSEcCtD
Maraviroc—Diarrhoea—Valproic Acid—epilepsy syndrome	2.65e-05	0.000164	CcSEcCtD
Maraviroc—Nervous system disorder—Topiramate—epilepsy syndrome	2.65e-05	0.000164	CcSEcCtD
Maraviroc—CCR5—Disease—IL6ST—epilepsy syndrome	2.65e-05	0.000265	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SOCS3—epilepsy syndrome	2.64e-05	0.000264	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CDC42—epilepsy syndrome	2.63e-05	0.000263	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.63e-05	0.000163	CcSEcCtD
Maraviroc—Skin disorder—Topiramate—epilepsy syndrome	2.63e-05	0.000162	CcSEcCtD
Maraviroc—CCR5—Disease—NOS2—epilepsy syndrome	2.62e-05	0.000263	CbGpPWpGaD
Maraviroc—Hypersensitivity—Pregabalin—epilepsy syndrome	2.58e-05	0.00016	CcSEcCtD
Maraviroc—Anorexia—Topiramate—epilepsy syndrome	2.58e-05	0.000159	CcSEcCtD
Maraviroc—Dizziness—Valproic Acid—epilepsy syndrome	2.56e-05	0.000159	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—AVP—epilepsy syndrome	2.55e-05	0.000255	CbGpPWpGaD
Maraviroc—Body temperature increased—Gabapentin—epilepsy syndrome	2.54e-05	0.000157	CcSEcCtD
Maraviroc—Abdominal pain—Gabapentin—epilepsy syndrome	2.54e-05	0.000157	CcSEcCtD
Maraviroc—Asthenia—Pregabalin—epilepsy syndrome	2.51e-05	0.000156	CcSEcCtD
Maraviroc—Pruritus—Pregabalin—epilepsy syndrome	2.48e-05	0.000153	CcSEcCtD
Maraviroc—Vomiting—Valproic Acid—epilepsy syndrome	2.47e-05	0.000152	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.46e-05	0.000152	CcSEcCtD
Maraviroc—Insomnia—Topiramate—epilepsy syndrome	2.45e-05	0.000151	CcSEcCtD
Maraviroc—Rash—Valproic Acid—epilepsy syndrome	2.44e-05	0.000151	CcSEcCtD
Maraviroc—Dermatitis—Valproic Acid—epilepsy syndrome	2.44e-05	0.000151	CcSEcCtD
Maraviroc—Headache—Valproic Acid—epilepsy syndrome	2.43e-05	0.00015	CcSEcCtD
Maraviroc—Paraesthesia—Topiramate—epilepsy syndrome	2.43e-05	0.00015	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HES1—epilepsy syndrome	2.41e-05	0.000241	CbGpPWpGaD
Maraviroc—Diarrhoea—Pregabalin—epilepsy syndrome	2.4e-05	0.000148	CcSEcCtD
Maraviroc—Hypersensitivity—Gabapentin—epilepsy syndrome	2.37e-05	0.000146	CcSEcCtD
Maraviroc—Decreased appetite—Topiramate—epilepsy syndrome	2.35e-05	0.000145	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FYN—epilepsy syndrome	2.34e-05	0.000234	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—H2AFX—epilepsy syndrome	2.34e-05	0.000234	CbGpPWpGaD
Maraviroc—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.33e-05	0.000144	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MEF2C—epilepsy syndrome	2.33e-05	0.000233	CbGpPWpGaD
Maraviroc—Fatigue—Topiramate—epilepsy syndrome	2.33e-05	0.000144	CcSEcCtD
Maraviroc—Dizziness—Pregabalin—epilepsy syndrome	2.32e-05	0.000143	CcSEcCtD
Maraviroc—Pain—Topiramate—epilepsy syndrome	2.31e-05	0.000143	CcSEcCtD
Maraviroc—Constipation—Topiramate—epilepsy syndrome	2.31e-05	0.000143	CcSEcCtD
Maraviroc—Asthenia—Gabapentin—epilepsy syndrome	2.31e-05	0.000143	CcSEcCtD
Maraviroc—Nausea—Valproic Acid—epilepsy syndrome	2.3e-05	0.000142	CcSEcCtD
Maraviroc—Pruritus—Gabapentin—epilepsy syndrome	2.27e-05	0.000141	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—YWHAZ—epilepsy syndrome	2.25e-05	0.000225	CbGpPWpGaD
Maraviroc—Vomiting—Pregabalin—epilepsy syndrome	2.23e-05	0.000138	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—NGF—epilepsy syndrome	2.23e-05	0.000223	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.21e-05	0.000137	CcSEcCtD
Maraviroc—Rash—Pregabalin—epilepsy syndrome	2.21e-05	0.000137	CcSEcCtD
Maraviroc—Dermatitis—Pregabalin—epilepsy syndrome	2.21e-05	0.000137	CcSEcCtD
Maraviroc—Diarrhoea—Gabapentin—epilepsy syndrome	2.2e-05	0.000136	CcSEcCtD
Maraviroc—Headache—Pregabalin—epilepsy syndrome	2.2e-05	0.000136	CcSEcCtD
Maraviroc—CCR5—Disease—FGF2—epilepsy syndrome	2.14e-05	0.000214	CbGpPWpGaD
Maraviroc—Abdominal pain—Topiramate—epilepsy syndrome	2.14e-05	0.000132	CcSEcCtD
Maraviroc—Body temperature increased—Topiramate—epilepsy syndrome	2.14e-05	0.000132	CcSEcCtD
Maraviroc—Dizziness—Gabapentin—epilepsy syndrome	2.13e-05	0.000131	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR2A—epilepsy syndrome	2.12e-05	0.000212	CbGpPWpGaD
Maraviroc—Nausea—Pregabalin—epilepsy syndrome	2.08e-05	0.000129	CcSEcCtD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	2.05e-05	0.000205	CbGpPWpGaD
Maraviroc—Vomiting—Gabapentin—epilepsy syndrome	2.04e-05	0.000126	CcSEcCtD
Maraviroc—Rash—Gabapentin—epilepsy syndrome	2.03e-05	0.000125	CcSEcCtD
Maraviroc—Dermatitis—Gabapentin—epilepsy syndrome	2.02e-05	0.000125	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—TSC2—epilepsy syndrome	2.02e-05	0.000202	CbGpPWpGaD
Maraviroc—Headache—Gabapentin—epilepsy syndrome	2.01e-05	0.000125	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—AGT—epilepsy syndrome	2.01e-05	0.000201	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.01e-05	0.000201	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2e-05	0.0002	CbGpPWpGaD
Maraviroc—Hypersensitivity—Topiramate—epilepsy syndrome	1.99e-05	0.000123	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	1.98e-05	0.000198	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOE—epilepsy syndrome	1.97e-05	0.000197	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	1.97e-05	0.000197	CbGpPWpGaD
Maraviroc—CCR5—Disease—MTOR—epilepsy syndrome	1.95e-05	0.000195	CbGpPWpGaD
Maraviroc—Asthenia—Topiramate—epilepsy syndrome	1.94e-05	0.00012	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—KDR—epilepsy syndrome	1.93e-05	0.000193	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—epilepsy syndrome	1.93e-05	0.000193	CbGpPWpGaD
Maraviroc—Pruritus—Topiramate—epilepsy syndrome	1.91e-05	0.000118	CcSEcCtD
Maraviroc—Nausea—Gabapentin—epilepsy syndrome	1.91e-05	0.000118	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PRKCB—epilepsy syndrome	1.86e-05	0.000186	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6ST—epilepsy syndrome	1.85e-05	0.000185	CbGpPWpGaD
Maraviroc—Diarrhoea—Topiramate—epilepsy syndrome	1.85e-05	0.000114	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	1.8e-05	0.00018	CbGpPWpGaD
Maraviroc—Dizziness—Topiramate—epilepsy syndrome	1.79e-05	0.000111	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	1.78e-05	0.000178	CbGpPWpGaD
Maraviroc—Vomiting—Topiramate—epilepsy syndrome	1.72e-05	0.000106	CcSEcCtD
Maraviroc—Rash—Topiramate—epilepsy syndrome	1.7e-05	0.000105	CcSEcCtD
Maraviroc—Dermatitis—Topiramate—epilepsy syndrome	1.7e-05	0.000105	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—POMC—epilepsy syndrome	1.69e-05	0.000169	CbGpPWpGaD
Maraviroc—Headache—Topiramate—epilepsy syndrome	1.69e-05	0.000105	CcSEcCtD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	1.66e-05	0.000166	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—epilepsy syndrome	1.66e-05	0.000166	CbGpPWpGaD
Maraviroc—Nausea—Topiramate—epilepsy syndrome	1.61e-05	9.93e-05	CcSEcCtD
Maraviroc—CCR5—Disease—SRC—epilepsy syndrome	1.56e-05	0.000156	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGF2—epilepsy syndrome	1.5e-05	0.00015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RELA—epilepsy syndrome	1.39e-05	0.000139	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.37e-05	0.000138	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MTOR—epilepsy syndrome	1.36e-05	0.000136	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT1—epilepsy syndrome	1.27e-05	0.000127	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASP3—epilepsy syndrome	1.25e-05	0.000125	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JUN—epilepsy syndrome	1.22e-05	0.000122	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP9—epilepsy syndrome	1.19e-05	0.000119	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT1—epilepsy syndrome	1.15e-05	0.000115	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SRC—epilepsy syndrome	1.09e-05	0.000109	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—epilepsy syndrome	1.06e-05	0.000106	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.04e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.04e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.04e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.04e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.04e-05	0.000104	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.04e-05	0.000104	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT1—epilepsy syndrome	9.7e-06	9.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	9.53e-06	9.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	9.53e-06	9.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PNPO—epilepsy syndrome	9.53e-06	9.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GAMT—epilepsy syndrome	9.53e-06	9.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—QDPR—epilepsy syndrome	8.86e-06	8.86e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA4—epilepsy syndrome	8.86e-06	8.86e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	8.83e-06	8.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COX3—epilepsy syndrome	8.33e-06	8.33e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	7.9e-06	7.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	7.9e-06	7.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	7.9e-06	7.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PFKL—epilepsy syndrome	7.9e-06	7.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	7.9e-06	7.9e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NEU1—epilepsy syndrome	7.22e-06	7.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UPB1—epilepsy syndrome	7.22e-06	7.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ATIC—epilepsy syndrome	7.22e-06	7.22e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	6.95e-06	6.95e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT1—epilepsy syndrome	6.79e-06	6.79e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GBE1—epilepsy syndrome	6.71e-06	6.72e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	6.71e-06	6.72e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	6.31e-06	6.31e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	6.14e-06	6.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NT5E—epilepsy syndrome	5.98e-06	5.99e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALAD—epilepsy syndrome	5.98e-06	5.99e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	5.71e-06	5.71e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	5.71e-06	5.71e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	5.59e-06	5.59e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADSL—epilepsy syndrome	5.47e-06	5.47e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GLUL—epilepsy syndrome	5.37e-06	5.37e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	5.27e-06	5.27e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	4.93e-06	4.93e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AQP1—epilepsy syndrome	4.78e-06	4.78e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	4.33e-06	4.33e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	4.33e-06	4.33e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	3.53e-06	3.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	3.44e-06	3.44e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	3.42e-06	3.42e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.08e-06	3.08e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.93e-06	2.94e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.92e-06	2.92e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.79e-06	2.79e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.76e-06	2.76e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TH—epilepsy syndrome	2.75e-06	2.75e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.29e-06	2.29e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.26e-06	2.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.2e-06	2.2e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.05e-06	2.05e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.79e-06	1.79e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.76e-06	1.76e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.51e-06	1.51e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.38e-06	1.38e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.2e-06	1.2e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKT1—epilepsy syndrome	6.05e-07	6.06e-06	CbGpPWpGaD
